HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A successful case of transcatheter arterial embolization with n-butyl-2-cyanoacrylate for pancreatic arteriovenous malformation.

Abstract
A 57-year-old man was referred and admitted to our hospital for treatment of a symptomatic pancreatic mass. Pancreatic arteriovenous malformation (AVM) was diagnosed based on the findings of contrast-enhanced computed tomography (CT) and angiography, and transcatheter arterial embolization (TAE) with N-butyl-2-cyanoacrylate (NBCA) was performed without complications. The patient's symptoms subsequently improved after TAE, and resolution of the pancreatic AVM was detected on contrast-enhanced CT performed six months after the embolization procedure. This case indicates that TAE with NBCA is a safe and effective treatment for pancreatic AVM.
AuthorsTetsuya Tatsuta, Tetsu Endo, Kiyotaka Watanabe, Keisuke Hasui, Naoya Sawada, Go Igarashi, Kenichiro Mikami, Koichi Shibutani, Fumiyasu Tsushima, Yoshihiro Takai, Shinsaku Fukuda
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 53 Issue 23 Pg. 2683-7 ( 2014) ISSN: 1349-7235 [Electronic] Japan
PMID25447650 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Contrast Media
  • Enbucrilate
Topics
  • Angiography
  • Arteriovenous Malformations (diagnostic imaging, therapy)
  • Contrast Media
  • Embolization, Therapeutic (methods)
  • Enbucrilate (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Pancreas (blood supply, diagnostic imaging)
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: